+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID07713758

Phase 1 Study of Oral Repinatrabit Tablet in Adults With Moderate Liver or Severe Kidney Impairment Compared to Adults With Normal Liver and Kidney Function

Led by Otsuka Pharmaceutical Development & Commercialization, Inc. · Updated on 2026-08-12

32

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how the body processes repinatrabit in adults with moderate liver impairment or severe kidney impairment compared to adults with normal liver and kidney function. This Phase 1 study aims to understand differences in drug processing among these groups, which is important for safe and effective treatment planning. The trial includes adults aged 18 to 65 years and is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc. Participants are divided into three groups those with moderate liver impairment, those with severe kidney impairment, and those with normal liver and kidney function matched by age, weight, and sex. Each participant receives a single oral dose of repinatrabit tablet under fasting conditions on Day 1. The study uses a parallel design to compare the pharmacokinetics of repinatrabit across the groups. Throughout the study, participants are monitored from Day 1 to Day 8 for plasma drug concentration levels and other pharmacokinetic measures. Safety assessments include tracking adverse events, vital signs, physical exams, laboratory tests, and ECG results up to Day 14. The studys total duration for each participant includes initial dosing followed by close monitoring to understand drug behavior and safety in different organ function conditions.

CONDITIONS

Brief Title

A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function

Research Team

O

Otsuka Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here